CALVIN MEIN, M.D.
Ophthalmology Physician · SAN ANTONIO, TX
Individual Active NPI 1164487617
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 902 | 31,063 | $14,203,916 | $4,364,045 | $3,441,434 |
| 2023 | 891 | 18,802 | $10,315,385 | $3,268,829 | $2,576,995 |
| 2022 | 787 | 10,522 | $5,339,442 | $2,563,400 | $2,020,777 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 16,500 | $34 | $27 |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 2,280 | $147 | $117 |
| 92134 | Imaging of retina | 2,177 | $40 | $30 |
| J0177 | Injection, aflibercept hd, 1 mg | 2,000 | $330 | $263 |
| J0178 | Injection, aflibercept, 1 mg | 1,654 | $824 | $656 |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 1,572 | $233 | $185 |
| 67028 | Injection of drug into eye | 1,571 | $133 | $100 |
| 92014 | Established patient complete exam of visual system | 942 | $126 | $88 |
| 92250 | Photography of the retina | 491 | $37 | $27 |
| J2778 | Injection, ranibizumab, 0.1 mg | 293 | $155 | $123 |
| 92012 | Established patient problem focused exam of visual system | 211 | $89 | $64 |
| 92004 | New patient complete exam of visual system | 159 | $149 | $105 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | F7842 | TX |
| Retina Specialist (Ophthalmology) Physician | 207WX0107X | F7842 | TX |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in Texas
- NPI 1417308149
- NPI 1366749343
- NPI 1972378941
- NPI 1013929728
- NPI 1922300425
- NPI 1790347748
- NPI 1902596497
- NPI 1952301384
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.